Prevention of stroke in patients with atrial fibrillation: a role of modern anticoagulants

被引：0
|
作者：
Anisimova, A. V. [1 ]
Gendlin, G. E.
Borisov, S. N.
机构：
[1] Pirogov Russian Natl Res Med Univ, Moscow, Russia
来源：
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2013年 / 113卷 / 09期
关键词：
cardioembolic stroke; atrial fibrillation; primary and secondary prevention; oral anticoagulant; warfarin; rivaroxaban; FACTOR XA INHIBITOR; RISK-FACTORS; RIVAROXABAN; WARFARIN; MANAGEMENT; APPENDAGE; SAFETY;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The review addresses the primary and secondary prevention of cardioembolic ischemic stroke, in particular, in patients with non-valvular atrial fibrillation. Indications and schemes of anticoagulation treatment, advantages in stroke prevention and difficulties in using of the common oral anticoagulant warfarin are discussed. The authors compare the mechanism of action, efficacy and safety of the peroral anticoagulant rivaroxaban with warfarin. Based on the results of large meta-analyses, it has been concluded that the efficacy of rivaroxaban is rather superior to warfarin, this drug has the same safety profile and is more convenient in use. During treatment, no laboratory monitoring of hemostasis indicators is needed. This drug can be recommended for prevention of cardioembolic stroke in patients with atrial fibrillation.
引用
收藏
页码：62 / 69
页数：8
相关论文
共 50 条
  • [21] Prevention of cardioembolic stroke: use of oral anticoagulants in patients with atrial fibrillation
    D'Alessandro, G
    Corso, G
    Bottacchi, E
    Campagnoni, MP
    Silvestri, G
    Polillo, C
    De Marchi, M
    Begliuomini, G
    Iannizzi, L
    Roveyaz, L
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 20 (03): : 167 - 170
  • [22] New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
    Hilleman, Daniel E.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2012, 4 (06) : 269 - 283
  • [23] Novel oral anticoagulants for stroke prevention in atrial fibrillation
    Taylor, Jennifer
    EUROPEAN HEART JOURNAL, 2012, 33 (12) : 1419 - 1420
  • [24] Oral anticoagulants for stroke prevention in patients with atrial fibrillation and previous intracranial hemorrhage
    Simone Birocchi
    Gian Marco Podda
    Internal and Emergency Medicine, 2017, 12 : 527 - 529
  • [25] New Anticoagulants for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
    Hoecht, T.
    Frick, M.
    Alber, H.
    Huber, K.
    JOURNAL FUR KARDIOLOGIE, 2012, 19 (3-4): : 55 - 62
  • [26] Guideline Adherence: Are Patients with Atrial Fibrillation Receiving Oral Anticoagulants for Stroke Prevention?
    Po, Helen L.
    Yu, Hui Fen
    Lin, Hsiao Chu
    Lin, Ya Ju
    Chen, Yi Min
    Chou, Chao Liang
    Chen, Lu An
    Huang, Ying Ting
    CEREBROVASCULAR DISEASES, 2014, 38 : 96 - 96
  • [27] Oral anticoagulants for stroke prevention in patients with atrial fibrillation and previous intracranial hemorrhage
    Birocchi, Simone
    Podda, Gian Marco
    INTERNAL AND EMERGENCY MEDICINE, 2017, 12 (04) : 527 - 529
  • [28] Controversies regarding the new oral anticoagulants for stroke prevention in patients with atrial fibrillation
    Mohanty, Bibhu D.
    Looser, Patrick M.
    Gokanapudy, Lakshmi R.
    Handa, Rishi
    Mohanty, Sudipta
    Choi, Sharon S.
    Goldman, Martin E.
    Fuster, Valentin
    Halperin, Jonathan L.
    VASCULAR MEDICINE, 2014, 19 (03) : 190 - 204
  • [29] Anticoagulants in the Prevention of Complications in Patients With Atrial Fibrillation
    Skibitsky, V. V.
    Kanorsky, S. G.
    KARDIOLOGIYA, 2012, 52 (12) : 75 - 79
  • [30] Novel Anticoagulants in Secondary Stroke Prevention after TIA or Minor Stroke in Patients with Atrial Fibrillation
    Diener, Hans-Christoph
    CEREBROVASCULAR DISEASES, 2013, 36 : 8 - 8
12345